Navigation Links
Isis Reports Financial Results and Highlights for First Quarter 2012
Date:5/8/2012

ata at the American Society of Clinical Oncology showing that treatment with OGX-427 produced a trend toward increased tumor cell death in patients with bladder cancer and preliminary Phase 2 data showing that treatment with OGX-427 decreased prostate specific antigen in patients with metastatic prostate cancer.
  • Xenon Pharmaceuticals selected a drug targeting the hepcidin-hemojuvelin pathway as a development candidate to treat anemia of inflammation, a common form of anemia.
  • Conference Call
    At 4:30 p.m. Eastern Time today, May 8, Isis will conduct a live webcast conference call to discuss this earnings release and related activities.  Interested parties may listen to the call by dialing 866-831-6162 and refer to passcode "ISIS 2012," or access the webcast at www.isispharm.com.  A webcast replay will be available for a limited time at the same address.

    About Isis Pharmaceuticals, Inc.
    Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 26 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer.  Isis' partner, Genzyme, plans to commercialize Isis' lead product, KYNAMRO, following regulatory approval, which is expected in 2012.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at www.isispharm.com.

    Forward Looking Statements
    This press release includes forward-looking statements regarding Isis Pharmaceuticals' financial position and outlook, Isis' business, and the therapeutic and commercial potential of Isis' technologies and products in development, including the business of Regulus, Isis' jointly owned subsidiary.
    '/>"/>

    SOURCE Isis Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Vanda Pharmaceuticals Reports First Quarter 2012 Results
    2. Landauer, Inc. Reports Fiscal 2012 Second Quarter Results
    3. Halozyme Reports First Quarter 2012 Financial Results
    4. MAP Pharmaceuticals Reports First Quarter of 2012 Financial Results
    5. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
    6. IRIDEX Reports 2012 First Quarter Results
    7. Cambrex Reports First Quarter 2012 Results
    8. Cadence Pharmaceuticals Reports First Quarter 2012 Financial Results
    9. Cumberland Pharmaceuticals Reports First Quarter 2012 Financial Results
    10. Sequenom, Inc. Reports Financial Results For The First Quarter Of 2012
    11. Neuland Labs Reports Financial Results For Fiscal Year 2012
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/30/2015)... , June 30, 2015  Ardelyx, Inc. (NASDAQ: ... cardio-renal, gastrointestinal and metabolic diseases, today announced that the ... 14, 2015, from 8:00 a.m.- 1:00 pm EDT in ... The Ardelyx senior management team will present an ... compound, tenapanor, which has completed Phase 2b clinical trials ...
    (Date:6/30/2015)... JERUSALEM , June 30, 2015 ... http://www.oramed.com ), a clinical-stage pharmaceutical Company focused on the ... the first patient has been screened in the Company,s ...  This U.S. based study will be performed under the ... the U.S. Food and Drug Administration (FDA). ...
    (Date:6/30/2015)... 2015 /PRNewswire/ – Small Cap IR issues report. Recently, ... custom Arrayit blood card technology to Vivos, Global Genome ... Vivos offers an impervious, impenetrable and permanent DNA storage ... child on Earth, a safe and secure nuclear blast-proof, ... allow the rapid collection, separation, drying and storage of ...
    Breaking Medicine Technology:Ardelyx to Host Inaugural R&D Investor Day in New York City on July 14, 2015 2Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study 2Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study 3Small Cap IR - Empowering the Age of Genetic Enlightenment 2
    (Date:6/30/2015)... ... June 30, 2015 , ... ADVOCATE, the ... have been awarded the exclusive billing agreements with Jackson Radiology Associates in Jackson, ... encompassing their proprietary suite of billing process software functionality called Experience Based Technology ...
    (Date:6/30/2015)... ... ... On June 26, 2015, Harper’s Bazaar Magazine in an article titled “5 ... not expect to cause acne flare-ups. The list includes pillowcases, cell phones, ... are clogged pores and bacteria and each of the named triggers unexpectedly creates a ...
    (Date:6/30/2015)... ... June 30, 2015 , ... Lakeview ... more than doubled the size of its medical staff to further enhance its ... which includes physicians, nurse practitioners and physician assistants -- now totals 17, compared ...
    (Date:6/30/2015)... ... 2015 , ... Family and professional dementia caregivers are invited ... 9, 2015 at the Hyatt Regency Denver Tech Center from 7:30 am-4:30 pm. ... Campbell, the wife and daughter of singer Glen Campbell, who will discuss their ...
    (Date:6/30/2015)... ... June 30, 2015 , ... From the moment a patient enters the office ... care that they receive and the luxury in which they are bathed. The ... proud to offer the same experience, just better! , Their office is a state-of ...
    Breaking Medicine News(10 mins):Health News:ADVOCATE Wins Billing Agreements with Jackson Radiology Associates 2Health News:A List of 5 Surprising Acne Triggers and the Latest Acne Treatment Options 2Health News:Lakeview Health, a Nationally Recognized Drug Rehabilitation Center in Florida, Doubles Size of Medical Staff 2Health News:Family of Singer Glen Campbell to Discuss Living with Dementia at the Alzheimer's Association of Colorado's 26th Annual Education Symposium 2Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 2Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 3Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 4
    ... Association of Urology (EAU) and Europa Uomo, the ... have entered into an,affiliated partnership as part of ... in Europe with regards to urological diseases. Professor ... this unique,EAU affiliated partnership, Europa Uomo will gain ...
    ... helpings of gravy and dessert at the holiday table are ... thought. According to a new research report recently appearing online ... diet that is high in fat and in sugar actually ... too much fat. This means these foods hit you with ...
    ... , SHENZHEN, China, Nov. 30 ... operating subsidiary Mellow Hope finalized contract details with one of ... promises additional increase in revenues for Hard to Treat Diseases ... the Indian company secures the supply of raw pharmaceutical material ...
    ... , MINNEAPOLIS, Nov. 30 A new study has found ... a current intention to shop for and possibly switch their Medicare ... Over the past four years, the "intention to switch" measure has ... not everyone with some intention to switch actually will leave their ...
    ... bills stack up , MONDAY, Nov. 30 (HealthDay News) -- ... differ in a number of ways but achieve the same ... , Legislation approved by the House of Representatives earlier this ... Senate is preparing to debate a proposal to expand coverage ...
    ... ... Institute of Women,s Health of North America in Florida will offer 2009 H1N1 influenza vaccination. ... visit our website to locate a convenient LOCATION near you or call 1-877-966-3672. ... (Vocus) November 30, 2009 ...
    Cached Medicine News:Health News:Western diets turn on fat genes 2Health News:Hard to Treat Diseases (HTDS) Closes 1 Million Dollar Contract Indian Pharmaceutical 2Health News:Hard to Treat Diseases (HTDS) Closes 1 Million Dollar Contract Indian Pharmaceutical 3Health News:More Seniors Considering Health Insurance Switch 2Health News:Health Reform: What's in It for You? 2Health News:Health Reform: What's in It for You? 3Health News:2009 H1N1 Influenza Vaccination Being Offered at Various Affiliated Campuses of the Institute of Women's Health of North America in Florida 2Health News:2009 H1N1 Influenza Vaccination Being Offered at Various Affiliated Campuses of the Institute of Women's Health of North America in Florida 3
    The adult blanket provides full coverage for patients of all sizes. The generous size and versatility of these blankets include extra material for the shoulders and feet. The foot drape also reduces ...
    This revolutionary system combines the CSZ Head Wrap and Patient Vest for a non-invasive whole body hypothermia system. This method of cooling the patient allows for early treatment that is fast, cos...
    The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
    The Bair Hugger outpatient blanket makes it easy to give your patients the benefit of prewarming and enhance patient comfort during outpatient procedures....
    Medicine Products: